Skip to content

The Antimicrobial Advocate, Volume 2, Issue 12

Highlights from this issue:

  • Overview of cefdinir
  • Cefdinir usage data in Nebraska
  • A study on cefdinir vs cephalexin for UTI’s

The Antimicrobial Advocate December 2025

 

Scroll To Top expand_less

Sign up for Email Updates

Please provide your details below to reach out to our ASAP team on any questions about Antimicrobial Stewardship.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Address*
Name*